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AbstrACt
Objective To investigate whether the incidence of 
dementia is related to residential levels of air and noise 
pollution in London.
Design Retrospective cohort study using primary care 
data.
setting 75 Greater London practices.
Participants 130 978 adults aged 50–79 years registered 
with their general practices on 1 January 2005, with no 
recorded history of dementia or care home residence.
Primary and secondary outcome measures A first 
recorded diagnosis of dementia and, where specified, 
subgroups of Alzheimer’s disease and vascular dementia 
during 2005–2013. The average annual concentrations 
during 2004 of nitrogen dioxide (NO
2), particulate matter 
with a median aerodynamic diameter ≤2.5 µm (PM2.5) and 
ozone (O3) were estimated at 20×20 m resolution from 
dispersion models. Traffic intensity, distance from major 
road and night-time noise levels (Lnight) were estimated 
at the postcode level. All exposure measures were linked 
anonymously to clinical data via residential postcode. HRs 
from Cox models were adjusted for age, sex, ethnicity, 
smoking and body mass index, with further adjustments 
explored for area deprivation and comorbidity.
results 2181 subjects (1.7%) received an incident 
diagnosis of dementia (39% mentioning Alzheimer’s 
disease, 29% vascular dementia). There was a positive 
exposure response relationship between dementia and all 
measures of air pollution except O
3, which was not readily 
explained by further adjustment. Adults living in areas 
with the highest fifth of NO2 concentration (>41.5 µg/m
3) 
versus the lowest fifth (<31.9 µg/m3) were at a higher risk 
of dementia (HR=1.40, 95% CI 1.12 to 1.74). Increases 
in dementia risk were also observed with PM2.5, PM2.5 
specifically from primary traffic sources only and Lnight, 
but only NO2 and PM2.5 remained statistically significant in 
multipollutant models. Associations were more consistent 
for Alzheimer’s disease than vascular dementia.
Conclusions We have found evidence of a positive 
association between residential levels of air pollution 
across London and being diagnosed with dementia, which 
is unexplained by known confounding factors.
bACkgrOunD   
Dementia, encompassing both vascular 
dementia and Alzheimer’s disease, is now 
reported as the leading cause of death in 
England and Wales, accounting for 12% 
of all registered deaths.1 While temporal 
changes in recording may have influenced 
how the underlying cause is now determined, 
more important are increases in longevity 
among the population at older ages, caused 
by declining trends in deaths from cardiovas-
cular and cerebrovascular disease.2 In terms 
of years of life lost, the Global Burden of 
Disease in 2013 ranked all dementia as the 
fifth leading cause,2 noting their increasing 
importance as a cause of death despite little 
change in age-standardised rates. There-
fore, primary prevention of all dementia is 
a major global public health concern for the 
coming decades.3 For Alzheimer’s disease 
for example, while it has been estimated 
that small delays in its onset and progression 
could significantly reduce its estimated future 
burden,4 research has primarily focused 
on lifestyle factors, where a large systematic 
review estimated that about a third of Alzhei-
mer’s disease may be attributable to poten-
tially modifiable risk factors such as smoking 
and physical inactivity.5 
More recently research has also extended 
to the role of environmental risk factors 
strengths and limitations of this study
 ► Annual concentrations during 2004 for  air and 
noise pollution exposure were modelled at a fine 
resolution, including near-road estimates of traffic 
pollution.
 ► Pollution data were anonymously linked to electron-
ic health records of over 100 000 older adults reg-
istered with 75 general practices in Greater London 
during 2005–2013.
 ► Incident dementia diagnoses were identified, includ-
ing Alzheimer’s disease and vascular dementia.
 ► The robustness of the results was tested for by ad-
justing for area deprivation and other comorbidities.
 ► Accuracy and completeness of primary care diag-
noses of dementia and subdiagnoses are a known 
issue.
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and dementia, where a large systematic review identi-
fied moderate evidence for an association with eight 
different factors including air pollution.6 While air pollu-
tion is a well-established risk factor for cardiovascular 
and respiratory disease,7 its role in relation to dementia 
is less well considered and understood.8 A recent system-
atic review of the epidemiological evidence linking 
air pollution to dementia-related outcomes identified 
18 studies, with most reporting adverse associations.9 
However, there was a significant variation in the size and 
quality of the studies involved, reiterating the noted lack 
of robust longitudinal or population-based studies.6 8 
Subsequently, a large population-based study in Ontario, 
Canada, reported that living close to major roads was 
associated with a higher incidence of dementia,10 with 
a further analysis revealing corresponding associations 
with modelled levels of nitrogen dioxide (NO2) and 
mass of fine particulate matter with a median aerody-
namic diameter ≤2.5 µm (PM2.5).
11 These findings raise 
questions around the mechanisms for the early develop-
ment of neuroinflammation and neurodegeneration,12 
and require further exploration and replication in other 
large population cohorts with different exposure models, 
including traffic noise which has been linked to cognitive 
decline in adults.13
In this paper, we use modelled estimates at a fine spatial 
scale for modelled estimates of air and noise pollution to 
investigate relationships with the incidence of dementia 
across Greater London.
MethODs
Data source
The Clinical Practice Research Datalink (CPRD) is a large, 
validated primary care database that has been collecting 
anonymous patient data from participating UK general 
practices since 1987.14 It has been shown to be broadly 
representative of the UK population, with about 7% of 
all people in the UK actively registered on it in 2011.14 
Approximately three-quarters of contributing CPRD 
practices in England have consented to their data being 
linked to external sources. This is facilitated by a ‘trusted 
third party’ to CPRD, ensuring that researchers have no 
access to geographical identifiers such as residential post-
code. Key variables which have been linked to the practice 
data include the Index of Multiple Deprivation (IMD), 
a composite small-area (approximately 1500 people) 
measure used in England for allocation of resources,15 
and the Office for National Statistics death registration 
data, which allows underlying cause of death to be identi-
fied. For this study, we selected 75 (linked) practices that 
lay within the study area bounded geographically by the 
orbital M25 motorway around Greater London (60 were 
in outer London boroughs, 15 were in inner London 
boroughs) that were continually recording data between 
2004 and 2010.16
estimates of air and noise pollution exposure
The following measures of exposure, estimated annually 
between 2004 and 2010, were linked to CPRD: (1) air 
pollution concentrations, (2) traffic intensity or distance 
measures, and (3) road traffic noise levels. A priori we 
chose to focus on annual concentrations estimated in 
2004 as this was the earliest year linked. Modelled esti-
mates in other years (2005–2010) were highly correlated 
(r>0.95), and repeating the analysis using alternative 
years produced identical results (data not shown).
Modelled annual concentrations for air pollutants were 
estimated using the KCLurban dispersion modelling 
system at a resolution of 20×20 m.17 It incorporates hourly 
meteorological measurements, empirically derived 
concentrations of NO-NO2-O3 and derived PM (particu-
late matter), using information on source emissions from 
the London Atmospheric Emissions Inventory.18 For this 
analysis, we focused on annual concentrations in 2004 
for NO2, PM2.5 (fine particulate matter with a median 
aerodynamic diameter ≤2.5 µm) and O3 (ozone). Addi-
tionally, we present an estimate for primary PM2.5 attrib-
utable to road traffic sources estimated from the sum of 
contributions from the following emission sources: tyre, 
brake, exhaust, surface wear and resuspension.17 Air 
pollution concentration estimates were derived for each 
of the 190 115 London postcodes address centroids based 
on interpolation from the closest 20×20 m point of the 
dispersion model.18 This resulted in patients residing 
in the same postcodes, which typically average about 15 
households nationally, being assigned the same exposure 
levels. Additionally, some postcodes covering smaller 
geographical areas may also be assigned to the same 
20×20 m point. The exposure concentrations were linked 
to CPRD by the ‘trusted third party’, who subsequently 
remove the postcode, ensuring we had no direct access to 
any geographical identifiers.
Traffic proximity measures were developed relating to 
‘heavy’ vehicle density, which was defined as light goods 
vehicles, heavy goods vehicles (rigid and articulated 
trucks/lorries), buses and coaches. We included a distance 
measure (in metres) from the postcode centroid to the 
nearest road classified in the top quartile of heavy vehicle 
intensity. Traffic intensity was estimated as total vehicle 
kilometre driven (heavy vehicles only) in each year for all 
major roads that fell within a 50 m and 50–100 m radius 
of the postcode address centroid. We used an arbitrary 
cut-off of >100 000 km driven to define ‘high volume’ in 
the analyses.
Road traffic noise levels were estimated using the 
TRAffic Noise EXposure (TRANEX) model.19 This 
uses information on road traffic flows and speeds, road 
geography, land cover, and building heights to estimate 
average sound pressure level (LAeq) in decibels (dB) over 
different time periods. Evaluations of TRANEX in two 
other English cities have shown high correlation (r≥0.85) 
between modelled and measured 1-hour LAeq.
19 In our 
analysis, we focused on the average annual Lnight recorded 
overnight between 23:00 and 07:00, as this period 
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represents when most of our study subjects would be at 
their residence. Alternative analyses using daytime noise 
(LAeq16) produced identical results (data not shown) 
due to the extremely high correlation with night noise 
(r=0.999).20 For the linkage of the noise model to CPRD, 
the geometric centroids of the address locations in each 
postcode were directly used.
Cohort definition
Among the 75 practices, a total of 555 385 patients were 
actively registered on 1 January 2005, representing about 
7% of the Greater London population at that time. From 
these, we selected 139 718 adults aged 50–79 years who 
had been registered for ≥1 year continuously with their 
practice. From this group, 131 869 (94%) were success-
fully linked to our pollution exposures. Non-linkage was 
mainly due to a few practices being near the study area 
boundary, so many of their patients’ individual post-
codes were not eligible. Patients were followed until the 
earliest of (1) date of first diagnosis of dementia, (2) 
date of death or deregistration from practice, (3) date 
when the practice ceased contributing to CPRD and (4) 
31 December 2013.
We searched the primary care records for the date of first 
dementia diagnosis, using the Read codes for dementia 
within the Quality and Outcomes Framework (QOF).21 
Although most Read codes are non-specific, we identified 
subgroups that classified the dementia as Alzheimer’s 
disease or vascular dementia. Using the death records, we 
also used the International Classification of Diseases 10th 
Revision codes to identify patients with dementia listed as 
the primary cause of death (if not coded as such on the 
general practitioner (GP) record), and to further classify 
them based on specific mention of Alzheimer’s disease or 
vascular dementia anywhere on the death record. We also 
extracted from the GP record information on ethnicity, 
smoking, body mass index (BMI) and alcohol consump-
tion, using the last measurement before baseline when 
available, or during the study if that was the only one avail-
able. A missing category was retained where no informa-
tion was available. In addition, we extracted information 
on comorbidity recorded at baseline, based on a list of 
conditions we have previously shown to be independently 
predictive of mortality.22
Patients (n=391) with an existing diagnosis of dementia 
by 1 January 2005 were excluded. Additionally, we sought 
to exclude patients (n=423) when there was evidence on 
their medical record that they were living in a residential 
or care home as of 1 January 2005. We did this through 
a combination of Read codes, or where four or more 
patients aged 65–99 were recorded living at the same 
address. We also excluded a small number of patients 
(n=77) where no IMD could be assigned. This resulted in 
130 978 eligible patients for our analyses.
statistical analyses
We used Cox proportional hazards models to investi-
gate the associations between all exposure measures 
estimated in the year before baseline (2004) and subse-
quent dementia incidence. To account for the clustering 
by practice (homogeneity between patients from the 
same practice), we fitted models with a shared frailty (at 
practice level), which are the survival data equivalent 
to random effects.23 We adjusted cumulatively for (1) 
age, sex, ethnicity, smoking and BMI (recorded alcohol 
consumption was not independently predictive and 
was dropped from the model), (2) IMD decile (based on 
national ranking across England) and (3) comorbidities 
(ischaemic heart disease (IHD), stroke, heart failure, 
diabetes) that were independently predictive of dementia. 
For model (2) we explored the effect of adjusting for 
other pollutants (air pollution for noise and vice versa). 
In sensitivity analyses, we explored within-practice and 
between-practice effects by fitting different models (a 
non-frailty model stratified on practice, practice fitted 
as a fixed effect, fitting practice mean exposure level in 
addition to individual level). For all pollutants, we fitted a 
continuous measure based on IQR to enable comparison 
between estimates, and quintiles to describe the shape of 
the association. All analyses were carried out in Stata V.13.
Patient and public involvement
No patients were involved in developing the research ques-
tion, outcome measures and overall design of the study. 
Due to patient anonymity, we are unable to disseminate 
the results of the research directly to study participants.
results
During the study follow-up period (mean=6.9 years), a 
total of 2181 patients (1.7%, incidence rate 2.4 per 1000 
per year) received a first diagnosis of dementia during 
follow-up (table 1). Among those patients diagnosed, 
848 (38.9%) had a mention of Alzheimer’s disease, 634 
(29.1%) mentioned vascular dementia, while 747 (34.3%) 
received a non-specific Read code. A total of 48 patients 
(2.2%) received diagnoses for both Alzheimer’s disease 
and vascular dementia. While crude incidence rates for 
dementia were lowest in smokers, later adjustment for age 
and other covariates explained this association; however, 
the lowest dementia risk seen in obese subjects persisted 
(data not shown).
The summary statistics for the modelled air and noise 
pollutants in 2004 are shown in table 2. All air pollutants 
were strongly positively related to each other (r>0.9), 
except for O3 which was negatively correlated (r=−0.9 or 
greater) with both NO2 and PM2.5. Night noise (Lnight) 
was positively related to NO2 and PM2.5, but associations 
were less in magnitude (r=0.3–0.4) to all air pollutants. 
A different pattern for noise was also observed when 
intraclass correlations (ICCs) were calculated by practice. 
While most variation by noise was observed within prac-
tices (ICC=0.05), the opposite was true for air pollutants 
where most variation was between practice (ICC>0.7). 
When mean concentrations were calculated by traffic 
distance and intensity (online supplementary table S1), 
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Table 1 Incidence rates of dementia during follow-up by characteristics of eligible subjects estimated at baseline 
Baseline 
variable Grouping
All subjects
First diagnosis of dementia 2005–2013†
Any
Alzheimer’s 
disease Vascular Non-specific
n % n IR* n IR* n IR* n IR*
All 130 978 100 2181 2.40 848 0.93 634 0.69 747 0.82
Sex Men 65 130 49.7 948 2.14 326 0.73 301 0.68 344 0.78
Women 65 848 50.3 1233 2.63 522 1.11 333 0.71 403 0.86
Age 50–59 59 587 45.5 99 0.23 38 0.09 17 0.04 45 0.11
60–69 41 013 31.3 427 1.49 175 0.61 102 0.36 155 0.54
70–79 30 378 23.2 1655 8.27 635 3.14 515 2.54 547 2.70
Ethnicity White 86 896 66.3 1791 2.84 703 1.11 524 0.83 607 0.96
Asian 7309 5.6 98 1.77 35 0.63 39 0.70 27 0.49
Black 4287 3.3 101 3.29 32 1.04 32 1.04 37 1.20
Unknown 32 486 24.8 191 0.98 78 0.40 39 0.20 76 0.39
Smoking Never 63 478 48.5 1108 2.42 473 1.03 293 0.64 362 0.79
Ex 33 063 25.2 715 3.10 264 1.14 235 1.01 235 1.01
Current 25 733 19.7 308 1.76 95 0.54 89 0.51 133 0.76
Missing 8704 6.7 50 1.09 16 0.35 17 0.37 17 0.37
BMI <20 5188 4.0 173 5.09 66 1.93 52 1.52 58 1.69
20–25 35 642 27.2 702 2.81 276 1.10 201 0.80 237 0.94
25–30 41 281 31.5 721 2.44 304 1.02 202 0.68 238 0.80
30+ 25 783 19.7 364 1.97 116 0.63 129 0.70 125 0.68
Missing 23 084 17.6 221 1.51 86 0.59 50 0.34 89 0.61
IHD Yes 9928 7.6 342 5.21 91 1.38 141 2.14 117 1.77
No 121 050 92.4 1839 2.18 757 0.89 493 0.58 630 0.74
Stroke Yes 3647 2.8 190 8.38 40 1.74 99 4.33 57 2.49
No 127 331 97.2 1991 2.24 808 0.91 535 0.60 690 0.77
Diabetes Yes 10 160 7.8 300 4.34 85 1.22 114 1.64 109 1.57
No 120 818 92.2 1881 2.24 763 0.90 520 0.62 638 0.76
Heart failure Yes 1704 1.3 62 6.76 9 0.97 26 2.81 27 2.92
No 129 274 98.7 2119 2.35 839 0.93 608 0.67 720 0.80
IMD‡ 1 (least) 26 149 20.0 426 2.21 163 0.84 132 0.68 144 0.75
2 31 452 24.0 535 2.36 212 0.93 146 0.64 188 0.83
3 26 093 19.9 401 2.29 179 1.02 112 0.64 119 0.68
4 30 817 23.5 514 2.49 187 0.90 160 0.77 176 0.85
5 (most) 16 467 12.6 305 2.78 107 0.97 84 0.76 120 1.09
Borough Inner 23 111 17.6 390 2.51 123 0.79 134 0.86 143 0.92
Outer 107 867 82.4 1791 2.37 725 0.96 500 0.66 604 0.80
Registration 
length (years)
<10 40 386 30.8 638 2.41 251 0.94 196 0.74 210 0.79
10+ 90 592 69.2 1543 2.39 597 0.92 438 0.68 537 0.83
*Incidence rate per 1000 patients per year.
†n=48 patients appear in both Alzheimer’s disease and vascular dementia categories.
‡These groups correspond to the fifths of the IMD ranking across England; thus, Greater London is under-represented in the most deprived 
fifth.
BMI, body mass index; IHD, ischaemic heart disease; IMD, Index of Multiple Deprivation.
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all pollutants declined with increasing distance from 
major roads, except O3 which was higher with further 
distance. While patients residing in postcodes closest to 
major roads (0–50 m) had much higher night noise levels 
than those farthest away (60.4 dB vs 50.9 dB), the differ-
ence in modelled air pollution concentrations, especially 
PM2.5, was much less.
Table 3 summarises a series of adjusted HRs for an 
incident diagnosis of dementia associated with compa-
rable interquartile changes in different pollutant expo-
sures. The strongest positive associations were seen for 
NO2, where a +7.5 µg/m
3 change produced an HR of 
1.16 (95% CI 1.05 to 1.28), adjusting for IMD and other 
confounders (HR2 in table 3). Further adjustment for 
related comorbidities (HR3=1.16) did not explain this 
association. Corresponding associations were smaller with 
other measures (PM2.5 HR=1.07, PM2.5 traffic HR=1.08, 
Lnight HR=1.02, distance from road HR=1.02) or nega-
tive (O3 HR=0.84). We explored different approaches 
in estimating within-practice and between-practice esti-
mates (online supplementary table S2). For NO2 and 
PM2.5the HRs were >1 for both estimates, but the CIs were 
wide. For night noise (Lnight), there was stronger evidence 
suggesting between-practice association (HR=1.42, 
95% CI 1.03 to 1.96). To investigate the shape of the asso-
ciation, figure 1 plots the adjusted HR (HR3 in table 3) 
by air and noise pollution fifths, and road distance and 
traffic intensity 50 m categories. The corresponding HRs 
are given in full in online supplementary table S3. For 
NO2 and PM2.5 the increase in dementia risk was notice-
ably higher in the top fifth of exposure. Patients with an 
assigned annual exposure of NO2 of >41.5 µg/m
3 had a 
marked increase in risk (HR=1.40, 95% CI 1.12 to 1.74) 
compared with those in the bottom fifth (<31.9 µg/m3). 
For other measures (noise, distance, intensity), there 
was less evidence of any trend, while for O3 the risk was 
highest in the lowest fifth of exposure (<34.7 µg/m3).
The associations between dementia and an interquar-
tile change (+7.5 µg/m3) in NO2 are explored further in 
figure 2, which plots the adjusted HRs (HR2 in table 3) 
from Cox models stratified on a series of risk factors. 
Generally, there was little evidence of any effect modifica-
tion across these factors, with all categories producing an 
HR >1. Associations between NO2 and dementia were still 
observed when restricted to patients registered for their 
practice continually for more than 10 years (HR=1.13, 
Table 3 Adjusted HRs for incident dementia during 2005–2013 by air and noise pollutants
Exposure IQR change HR1* (95% CI) HR2† (95% CI) HR3‡ (95% CI) HR4§ (95% CI)
NO2 +7.47 µg/m
3 1.17 (1.06 to 1.28) 1.16 (1.05 to 1.28) 1.16 (1.05 to 1.27) 1.15 (1.04 to 1.28)
PM2.5 +0.95 µg/m
3 1.07 (1.02 to 1.12) 1.07 (1.02 to 1.12) 1.06 (1.02 to 1.12) 1.06 (1.01 to 1.13)
PM2.5 (traffic) +0.58 µg/m
3 1.09 (1.02 to 1.17) 1.08 (1.01 to 1.16) 1.08 (1.01 to 1.16) 1.08 (0.99 to 1.18)
O3 +5.56 µg/m
3 0.84 (0.75 to 0.93) 0.84 (0.75 to 0.94) 0.85 (0.76 to 0.94) 0.85 (0.76 to 0.96)
Lnight +2.68 dB 1.02 (1.00 to 1.05) 1.02 (1.00 to 1.05) 1.02 (1.00 to 1.05) 1.01 (0.98 to 1.03)
Distance to major road −310 m 1.02 (0.97 to 1.08) 1.02 (0.97 to 1.08) 1.02 (0.97 to 1.08) 1.00 (0.95 to 1.05)
*HR1: Cox model with practice fitted as shared frailty. Adjusted for age, sex, ethnicity, smoking and body mass index.
†HR2: As HR1, plus additional adjustment for Index of Multiple Deprivation.
‡HR3: As HR2, plus additional adjustment for comorbidity (ischaemic heart disease, stroke, diabetes, heart failure).
§HR4: As HR2, plus additional adjustment for Lnight (NO2 and PM2.5 estimates) or NO2 (Lnight and distance estimates).
Lnight, night-time noise levels; NO2, nitrogen dioxide; O3, ozone; PM2.5, particulate matter ≤2.5 µm.  
Table 2 Summary statistics for the annual concentrations in 2004 of air (NO2, PM2.5, PM2.5 traffic, O3) and noise (Lnight) 
pollutants
Summary 
statistics
NO2
(μg/m3)
PM2.5
(μg/m3)
PM2.5 (traffic)
(μg/m3)
O3
(μg/m3)
Lnight
(dB)
Mean±SD 37.1±5.7 15.7±0.8 1.4±0.5 38.0±3.9 52.1±4.6
Median (IQR) 36.4 (32.9–40.4) 15.6 (15.2–16.1) 1.3 (1.1–1.7) 38.2 (35.5–41.0) 49.9 (49.4–52.1)
Correlation 
coefficients
NO2   – 0.98 0.94 −0.99 0.33
PM2.5 0.98   – 0.97 −0.96 0.39
PM2.5 (traffic) 0.94 0.97   – −0.90 0.51
O3 −0.99 −0.96 −0.90   – −0.27
Lnight 0.33 0.39 0.51 −0.27   – 
ICC (practice)* 0.87 0.83 0.68 0.92 0.05
*Intraclass coefficient calculated across practice clusters.
Lnight, night-time noise levels; NO2, nitrogen dioxide; O3, ozone; PM2.5, particulate matter ≤2.5 µm. 
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95% CI 1.01 to 1.26), or to patients without IHD, stroke, 
diabetes or heart failure at baseline (HR=1.21, 95% CI 
1.08 to 1.34).
We repeated the analysis, now subclassifying dementia 
diagnoses recorded as Alzheimer’s disease, vascular 
dementia or non-specific where no further information 
was available (table 4). The positive associations with NO2 
and PM2.5 were more consistent for Alzheimer’s disease 
and non-specific diagnoses. For example, patients in the 
top fifth exposure category of NO2 (>41.5 µg/m
3) were at 
a higher risk of receiving an Alzheimer’s disease diagnosis 
than patients in the bottom fifth (HR=1.50, 95% CI 1.08 
to 2.08). For vascular dementia, there was less evidence of 
consistent effects with air or noise pollution.
DisCussiOn
In a sample of 75 general practices across Greater London, 
the recording of new dementia diagnoses was positively 
associated with measures of NO2 and PM2.5 assigned at resi-
dential address at the beginning of the incident period. 
The association could not be explained by confounding 
and was consistent within subgroups. When we restricted 
to specific diagnoses, associations were still observed with 
Alzheimer’s disease but not vascular dementia.
strengths and weaknesses
While we were able to link pollution exposures to the 
primary care record to obtain diagnoses of dementia, 
there are concerns around the variability of dementia 
diagnoses in UK primary care,24 and a recent review has 
concluded that dementia diagnoses on primary care data-
bases may not be an accurate reflection of the true prev-
alence.25 Under-recording is thought to be a common 
issue, as the diagnosis is associated with a stigma for many, 
and GPs may be reluctant to diagnose dementia unless 
highly certain.26 A recent study across 23 London prac-
tices increased the prevalence on their QOF dementia 
registers by 9% by a simple coding review.26 To account 
for under-recording at baseline, a priori we decided to 
exclude all patients identified as living in care homes at 
the beginning of follow-up regardless of dementia diag-
nosis. During follow-up, we observed broadly similar 
number of dementia subtypes being newly diagnosed, 
and since it is expected that about two-thirds of dementia 
is Alzheimer’s disease,27 this suggests the under-re-
cording of Alzheimer’s disease in particular may be an 
issue. Under-recording in our study could be problem-
atic if it was related to key practice characteristics such 
as deprivation, as dementia recording has been shown 
to be lower among more affluent practices.24 28 In our 
Figure 1 Adjusted HRs for all incident dementia during 2005–2013 by air and noise pollution fifths and traffic distance and 
intensity categories. HRs estimated from the Cox model with practice fitted as shared frailty. Adjusted for age, sex, ethnicity, 
smoking, body mass index and Index of Multiple Deprivation. HRs are given in full in online supplementary table S3. Lnight, night-
time noise levels; NO2, nitrogen dioxide; O3, ozone; PM2.5, particulate matter ≤2.5 µm. 
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study we observed a wide range of incident rates by prac-
tice (0.2%–8.4%), and since the majority of air pollu-
tion variation was between practices we cannot discount 
unmeasured practice characteristics as a possible expla-
nation for our findings. There are also known variations 
in the prevalence and diagnosis rates of dementia across 
England,24 with London being among the reported 
lowest,29 so we also have to acknowledge that the associa-
tions we observed may be specific within London and may 
not extend nationally.
Another weakness of the study is the lack of historical 
data surrounding exposure. Most large epidemiolog-
ical studies of long-term exposure to pollution will have 
difficulty capturing an accurate picture of lifetime or 
cumulative exposure. This may be pertinent for Alzhei-
mer’s disease where the pathogenesis of the disease may 
take place over many years.30 We did not have any infor-
mation relating to previous address or location, and 
the London population is thought to be mobile and 
dynamic over time.31 Thus, we are making an assump-
tion that an annual estimate for a single year (2004) 
represents long-term exposure, based on the last known 
address for the patient at that practice. We tested this 
in two ways: (1) sensitivity analyses based on patients 
who had been continually registered at their practice 
for a long time (>10 years) produced similar findings; 
(2) where we did have other modelled years avail-
able during follow-up (2005–2010), these were highly 
correlated over time (r>0.95), so alternative analyses 
using them made no discernible difference. However, 
we cannot discount historical factors as an explanation 
for our findings. For example, it could be that recent 
exposure levels are acting as a proxy for other histor-
ical environmental factors linked to pollution, such as 
lead from petrol,32 where cumulative exposure has been 
linked to cognitive decline in later life.33
A novel aspect of our analysis was the ability to simul-
taneously study the modelled effects of air and noise 
pollution on dementia, overcoming acknowledged 
limitations from other studies.11 34 Previous validation 
of the pollution models used in this study had shown 
low roadside correlation between them, suggesting 
that the independent effects of traffic pollution and 
road noise can be investigated.20 However, a potential 
limitation is that by being based within Greater London, 
our air pollution exposure estimates may be somewhat 
homogeneous, lacking the variability we would expect 
to see nationally when more rural geographical areas 
are included. Within London, the contribution of 
regional (background) PM2.5 and O3 to overall levels 
Figure 2 Stratified adjusted HRs for an interquartile increase (7.5 µg/m3) in NO2 and all incident dementia during 2005–2013. 
HRs estimated from Cox model with practice fitted as shared frailty. Adjusted for age, sex, ethnicity, smoking, body mass 
index and IMD. P values for interaction tests: age (p=0.75), sex (p=0.27), smoking (p=0.47), comorbidity (p=0.31), IMD (p=0.72), 
registration length (p=0.62) and practice borough (p=0.63). DM, diabetes mellitus; HF, heart failure; IHD, ischaemic heart 
disease; IMD, Index of Multiple Deprivation; NO2, nitrogen dioxide. 
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tends to dominate.17 However, we were able to make use 
of a dispersion model with exceptionally fine resolution 
(20×20 m) to estimate significant changes in exposure 
of air pollution such as NO2, between major roads and 
suburban background locations.17 Despite this, the 
reality was that subtle roadside changes predicted by the 
model were small in comparison with larger differences 
estimated between the areas represented by the GP prac-
tices (ICCs>0.7 for all air pollutants), suggesting most 
modelled air pollution variation was between (practice) 
areas.16 While this limited statistical power to test for 
any within-practice effects in the study, we did not find 
evidence to suggest that the overall associations with 
NO2 and PM2.5 were entirely explained by between-prac-
tice differences in modelled exposures.
Finally, another limitation was the incomplete infor-
mation on key confounders and reliance on an area-
based measure (IMD) for socioeconomic status. While 
mid-life obesity is a risk factor for Alzheimer’s disease,5 
the BMI measures we extracted around baseline showed 
that the risk declined with obesity in later life, a finding 
which has been observed elsewhere.35 However, further 
adjustment for IHD, stroke, diabetes and heart failure, 
which would be associated with earlier unmeasured risk 
Table 4 HRs for incident Alzheimer’s disease, vascular and non-specific dementia during 2005–2013 by air and noise 
pollutants
Exposure
Category (or IQR 
change)
Alzheimer’s disease Vascular dementia Non-specific
HR2* (95% CI) HR2* (95% CI) HR2* (95% CI)
NO2 (µg/m
3) 0–31.9 1 (reference) 1 (reference) 1 (reference)
>31.9–35.2 0.98 (0.74 to 1.28) 0.94 (0.69 to 1.29) 1.09 (0.84 to 1.40)
>35.2–37.5 0.99 (0.73 to 1.35) 0.83 (0.57 to 1.20) 1.08 (0.82 to 1.43)
>37.5–41.5 1.15 (0.84 to 1.58) 0.98 (0.66 to 1.44) 1.01 (0.75 to 1.35)
>41.5 1.50 (1.08 to 2.08) 1.01 (0.66 to 1.55) 1.55 (1.16 to 2.07)
+7.5 (IQR change) 1.23 (1.07 to 1.43) 1.15 (0.96 to 1.39) 1.13 (0.99 to 1.28)
PM2.5 (µg/m
3) 0–15.1 1 (reference) 1 (reference) 1 (reference)
>15.1–15.4 1.01 (0.77 to 1.32) 0.89 (0.66 to 1.20) 1.00 (0.77 to 1.28)
>15.4–15.7 1.13 (0.84 to 1.52) 0.72 (0.50 to 1.02) 1.13 (0.86 to 1.47)
>15.7–16.3 1.24 (0.92 to 1.68) 0.91 (0.63 to 1.32) 1.00 (0.76 to 1.33)
>16.3 1.42 (1.03 to 1.96) 0.86 (0.57 to 1.30) 1.33 (0.99 to 1.77)
+0.9 (IQR change) 1.10 (1.02 to 1.18) 1.06 (0.97 to 1.16) 1.06 (0.99 to 1.13)
PM2.5traffic 
(µg/m3)
0–1.04 1 (reference) 1 (reference) 1 (reference)
>1.04–1.22 1.00 (0.76 to 1.30) 1.14 (0.86 to 1.52) 1.07 (0.84 to 1.38)
>1.22–1.42 1.09 (0.82 to 1.45) 0.92 (0.66 to 1.27) 1.06 (0.81 to 1.38)
>1.42–1.75 1.23 (0.93 to 1.64) 0.90 (0.63 to 1.28) 0.97 (0.73 to 1.27)
>1.75 1.46 (1.08 to 1.98) 0.99 (0.68 to 1.44) 1.33 (1.00 to 1.75)
+0.58 (IQR change) 1.13 (1.02 to 1.26) 1.08 (0.95 to 1.23) 1.08 (0.97 to 1.19)
O3 (µg/m
3) 0–34.7 1 (reference) 1 (reference) 1 (reference)
>34.7–37.3 0.83 (0.65 to 1.07) 0.88 (0.63 to 1.24) 0.68 (0.52 to 0.89)
>37.3–39.1 0.64 (0.48 to 0.86) 0.81 (0.55 to 1.17) 0.76 (0.58 to 1.00)
>39.1–41.8 0.62 (0.46 to 0.85) 0.82 (0.55 to 1.23) 0.73 (0.55 to 0.96)
>41.8 0.67 (0.48 to 0.94) 0.92 (0.59 to 1.43) 0.67 (0.50 to 0.90)
+5.6 (IQR change) 0.78 (0.66 to 0.92) 0.88 (0.71 to 1.09) 0.87 (0.76 to 1.01)
Lnight (dB) 0–49.4 1 (reference) 1 (reference) 1 (reference)
>49.4–49.6 0.95 (0.76 to 1.18) 1.22 (0.94 to 1.58) 1.07 (0.85 to 1.34)
>49.6–50.3 0.96 (0.77 to 1.20) 1.23 (0.94 to 1.59) 0.97 (0.77 to 1.23)
>50.3–53.8 0.94 (0.75 to 1.18) 1.17 (0.90 to 1.52) 0.93 (0.73 to 1.19)
>53.8 1.05 (0.84 to 1.31) 1.09 (0.83 to 1.42) 1.14 (0.91 to 1.43)
+2.7 (IQR change) 1.03 (0.99 to 1.07) 1.00 (0.96 to 1.05) 1.03 (0.99 to 1.07)
*HR2: Cox model with practice fitted as shared frailty. Adjusted for age, sex, ethnicity, smoking, alcohol consumption, body mass index and 
Index of Multiple Deprivation. For each exposure, models fit either quintiles with reference category, or IQR change.
Lnight, night-time noise levels; NO2, nitrogen dioxide; O3, ozone; PM2.5, particulate matter ≤2.5 µm.
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factors, including individual socioeconomic status, did 
not explain our findings.
Context
The established body of epidemiological evidence linking 
long-term concentrations of air pollution to adverse 
health effects has mainly focused on cardiovascular 
disease.36 The Global Burden of Disease studies, which 
have described the worldwide impact of air pollution, 
considered a wide range of outcomes (IHD, stroke, lung 
cancer, chronic obstructive pulmonary disease) but did 
not consider neurodegenerative outcomes.7 Research 
linking air pollution exposure to neurocognitive function 
has gradually increased from observational findings in 
2002 from dogs in Mexico City,37 to larger studies which 
assessed cognitive decline,38 39 and large population 
cohorts that specifically investigated the association in 
relation to diagnoses of dementia.10 11 40–43
A 2015 review on the effect of long-term exposure to 
outdoor air pollution (15 studies) and noise (8 studies) 
on cognitive and psychological functions in adults showed 
that both exposures were separately shown to be asso-
ciated with one or several measures of global cognitive 
function, but no study considered both exposures simul-
taneously, which they highlighted as a need for further 
research.34 The same authors followed with data from 
the Heinz Nixdorf Recall cohort study13 on 4086 adults 
using an additively calculated global cognitive score. They 
concluded ‘air pollution and road traffic noise might act 
synergistically on cognitive function in adults’. Our study 
could consider both measures (air pollution and night 
noise), and while both showed independent associations 
with dementia, in a combined model any associations 
with noise were diminished and of borderline statistical 
significance.
The largest cohort studies to date investigating dementia 
and long-term exposure to air pollution are from North 
America.10 11 43 Chen et al10 11 used a large Canadian 
population-based cohort of over 2 million adults aged 
55–85 years to ascertain approximately 250 000 incident 
dementia cases during 2001–2013. In their first analysis,10 
the authors found that the risk of dementia increased 
with nearness to a major road (adjusted HR=1.07, 95% CI 
1.06 to 1.08, for people living <50 m from a major traffic 
road versus >300 m). Associations were stronger among 
urban residents, especially those who lived in major cities. 
In a subsequent analysis,11 they used land-use regres-
sion models to estimate associations between incident 
dementia and air pollution, finding significant positive 
associations with both PM2.5 and NO2, and smaller nega-
tive associations with O3. An IQR increase in PM2.5 (4.8µg/
m3) was associated with an HR of 1.04 (95% CI 1.03 to 
1.05), while for NO2 (14.2 parts per billion) HR was esti-
mated to be 1.10 (95% CI 1.08 to 1.12). By comparison, 
our estimated distribution of the same pollutants within 
Greater London was much less spread, with IQRs approx-
imately one-quarter in size. Therefore, comparative HRs 
for similar unit changes in our study are much greater 
(eg, for a 1 µg/m3 change in PM2.5 the HR would be 1.07 
compared with 1.01 from the Canadian study, for NO2 
this would be 1.02 vs 1.00). Our estimate for PM2.5 was 
more in line what was found in a large US study of Medi-
care enrollees for first-ever hospitalisation for dementia 
during 1999–2010 (HR=1.08, 95% CI 1.05 to 1.11, for 
a 1 µg/m3 change in PM2.5). Chen et al
11 speculate that 
the stronger associations observed with NO2 may be in 
part due to it better capturing fine-scale variability in traf-
fic-related air pollution, whereas PM2.5 and O3 have larger 
regional components. However the resolution of their air 
pollution models was coarser (1×1 km resolution) than in 
our study (20×20 m) and may not capture primary emis-
sions from road traffic. While our models were able to 
estimate traffic-specific components of PM2.5,
17 effect esti-
mates remained higher for NO2.
Some smaller studies have separated Alzheimer’s 
disease from dementia. In Europe, a 15-year longitudinal 
study in northern Swedish city found evidence of positive 
associations with both vascular dementia and Alzheimer’s 
disease and nitrogen oxide using a land-use regression 
model with a spatial resolution of 50×50 m.41 Comparison 
between participants in the highest quartile of residential 
exposure at baseline, versus those in the lowest, produced 
similar estimates for Alzheimer’s disease (HR=1.38) and 
vascular dementia (HR=1.47). There have been recent 
cohort studies from Taiwan: Jung et al40 showed long-term 
exposure to O3 and PM2.5 was shown to increase the risk 
of Alzheimer’s disease, while Chang et al42 found associa-
tions between dementia and NO2 and carbon monoxide. 
A smaller case–control study by Wu et al44 linked PM10 
and O3 to an increased risk of Alzheimer’s disease and 
(vascular) dementia. In our study, lower O3 was negatively 
associated with risk of dementia, primarily as a result of 
the strong negative correlation with the other modelled 
air pollutants.45
implications
The implications of linking exposure to air pollution 
such as NO2 to the development of dementia, specifically 
Alzheimer’s disease, raise many questions.12 The cause of 
these neurodegenerative diseases is still largely unknown 
and may be multifactorial.8 While toxicants from air 
pollution have several plausible pathways to reach the 
brain, how and when they may influence neurodegener-
ation remains speculative.8 30 46 Traffic-related air pollu-
tion has been linked to poorer cognitive development 
in young children,47 and continued significant expo-
sure may produce neuroinflammation and altered brain 
innate immune responses in early adulthood.48 In later 
life, the risk for accelerated cognitive decline may involve 
gene–environment interactions, such as that with apoli-
poprotein E,49 where evidence comes from findings in 
neurotoxicological experiments with mice.50
Our observation of an association of air pollution with 
new dementia diagnoses among older adults living in 
Greater London is in contrast to an earlier analysis on 
these data which failed to show consistent associations 
 o
n
 12 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022404 on 11 September 2018. Downloaded from 
10 Carey IM, et al. BMJ Open 2018;8:e022404. doi:10.1136/bmjopen-2018-022404
Open access 
between air pollution and cardiorespiratory outcomes.16 
These suggest there may be a geographical pattern 
specific to dementia, and potentially Alzheimer’s disease, 
which requires further exploration nationally. In the 
Ontario cohort, Chen et al estimated that 6.1% of their 
total dementia cases were attributable to elevated air 
pollution exposure.11 In our study, a theoretical shift of 
all patients to the bottom 20% of NO2 exposure produces 
an attributable fraction of 7% (data not shown). While 
this would be smaller than previous population attribut-
able fraction (PAF) estimates for dementia in the UK for 
a range of independent risk factors such as for hyperten-
sion or obesity,5 even a small PAF for dementia would be 
impactful, where environmental risk factors such as air 
pollution can be more easily modified at the population 
level.30 There would be significant public health gains 
even if the impact was only to delay the progression of 
dementia.4
With the future global burden of dementia likely to 
be substantial,3 further epidemiological work is urgently 
needed to confirm and understand better recent findings 
linking air pollution to dementia.8 30 Our results suggest 
both regional and urban background pollutants may be 
as important as near-traffic pollutants. Future large-scale 
studies will need to rely on improved recording and 
linkage of dementia diagnoses across electronic systems, 
particularly Alzheimer’s disease, where multiple sources 
can improve diagnostic accuracy.25 Since exposure is life-
long, and most cases are diagnosed in later life, historical 
data are also ideally required to better estimate cumu-
lative exposure over preceding decades. In conclusion, 
our findings add to a growing evidence base linking air 
pollution and neurodegeneration and should encourage 
further research in this area.
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